Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study
利用真实世界数据开展博舒替尼治疗肌萎缩侧索硬化症的 II 期研究方案:基于诱导多能干细胞的肌萎缩侧索硬化症药物再利用 (iDReAM) 研究
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-082142
Imamura, Keiko; Izumi, Yuishin; Egawa, Naohiro; Ayaki, Takashi; Nagai, Makiko; Nishiyama, Kazutoshi; Watanabe, Yasuhiro; Murakami, Takenobu; Hanajima, Ritsuko; Kataoka, Hiroshi; Kiriyama, Takao; Nanaura, Hitoki; Sugie, Kazuma; Hirayama, Takehisa; Kano, Osamu; Nakamori, Masahiro; Maruyama, Hirofumi; Haji, Shotaro; Fujita, Koji; Atsuta, Naoki; Tatebe, Harutsugu; Tokuda, Takahiko; Takahashi, Naoto; Morinaga, Akiko; Tabuchi, Riko; Oe, Motoki; Kobayashi, Mihoko; Lobello, Kasia; Morita, Satoshi; Sobue, Gen; Takahashi, Ryosuke; Inoue, Haruhisa